(Q40440616)

20 September 2017

1 reference

title

Invasive aspergillosis in systemic lupus erythematosus (English)

1 reference

20 September 2017

0 references

invasive aspergillosis

1 reference

systemic lupus erythematosus

inferred from title

1 reference

Gonzalez-Crespo MR

1

1 reference

PubMed ID

7604298

20 September 2017

Gomez-Reino JJ

series ordinal

2

1 reference

20 September 2017

1 April 1995

1 reference

Seminars in Arthritis and Rheumatism

20 September 2017

1 reference

20 September 2017

24

1 reference

20 September 2017

5

1 reference

20 September 2017

304-314

1 reference

20 September 2017

Invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

1 reference

7 January 2021

Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

Invasive pulmonary aspergillosis in nonimmunocompromised, nonneutropenic hosts

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

The course of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

The bimodal mortality pattern of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

Computer analysis of factors influencing frequency of infection in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

Fever in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

A multicenter study of outcome in systemic lupus erythematosus. II. Causes of death

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

Infection in Immunologically-mediated Diseases: A Review

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

Fatal infections in systemic lupus erythematosus: the role of opportunistic organisms.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

Cryptococcal meningitis as a complication of systemic lupus erythematosus treated with systemic corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

Pulmonary nocardiosis. Occurrence in men with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

Toxoplasmosis in the central nervous system.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

Fungal diseases in a general hospital; a study of 88 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

Fungus Infection in Steroid-Treated Systemic Lupus Erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

The lung in systemic lupus erythematosus. Analysis of the pathologic changes in 120 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

Fungal and yeast infections of the central nervous system. A clinical review.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

Pulmonary aspergillosis due to Aspergillus terreus combined with staphylococcal pneumonia and hepatic candidiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

Purulent meningitis due to aspergillosis in a patient with systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

Infection in patients with systemic lupus erythematosus. Association with a serum inhibitor of complement-derived chemotactic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

Diagnosing fungal infections in immunocompromised hosts

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

Systemic fungal infections: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

Invasive pulmonary aspergillosis in an apparently nonimmunocompromised host

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

Invasive aspergillosis of the lung and pericardium in a nonimmunocompromised 33 year old man

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

Disseminated aspergillosis in a presumably immunocompetent host

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

Primary cutaneous aspergillosis associated with Hickman intravenous catheters

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

The compromised host as sentinel chicken

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

Fatal pulmonary aspergillosis presenting as acute eosinophilic pneumonia in a previously healthy child

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

Experience of invasive aspergillosis in Hong Kong

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

Central nervous system aspergillosis following steroidal therapy for allergic bronchopulmonary aspergillosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

Aspergillosis complicating neoplastic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

Fungal infections in patients with acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

Pulmonary Infections in Renal Transplant Recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

Invasive aspergillosis. Progress in early diagnosis and treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

10 year review of invasive aspergillosis detected at necropsy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

Factors associated with invasive lung aspergillosis and the significance of positive Aspergillus culture after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

Acquired immune deficiency syndrome: is disseminated aspergillosis predictive of underlying cellular immune deficiency?

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

Pulmonary aspergillosis in the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

Aspergillosis in the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

Invasive aspergillosis in patients with acquired immunodeficiency syndrome: report of 33 cases. French Cooperative Study Group on Aspergillosis in AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

Fungal infection in chronic granulomatous disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

Infectious complications in heart transplant recipients receiving cyclosporine and corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

Corticosteroid treatment as a risk factor for invasive aspergillosis in patients with lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

In vitro and in vivo antifungal activities of BMY-28864, a water-soluble pradimicin derivative

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

Nonresolving pneumonia in steroid-treated patients with obstructive lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus. Observations on these two lines of defense in vivo and in vitro with human and mouse phagocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

Mechanisms of resistance of Aspergillus fumigatus Conidia to killing by neutrophils in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

Neutrophils and host defense

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

In vitro killing of spores and hyphae of Aspergillus fumigatus and Rhizopus oryzae by rabbit neutrophil cationic peptides and bronchoalveolar macrophages.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

Phagocytic and fungicidal activity of monocytes from patients with acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

Interferon-gamma, the activated macrophage, and host defense against microbial challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

Partial correction of the phagocyte defect in patients with X-linked chronic granulomatous disease by subcutaneous interferon gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

Defective reticuloendothelial system Fc-receptor function in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

Impairment of neutrophil antifungal activity against hyphae of Aspergillus fumigatus in children infected with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

A specific inhibitor of complement (C5)-derived chemotactic activity in serum from patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

Salmonellosis and systemic lupus erythematosus. Report of ten cases

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

Inhibition of complement by culture supernatants of Aspergillus fumigatus.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

Monocyte function in the acquired immune deficiency syndrome. Defective chemotaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

Prognostic indicators in fungemia of the surgical patient

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

The microbial etiology and antimicrobial therapy of adults with acute community-acquired sinusitis: a fifteen-year experience at the University of Virginia and review of other selected studies

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

Acute pancreatitis in systemic lupus erythematosus: report of a case unrelated to drug therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

Diagnostic success of bronchoscopic biopsy in immunocompromised patients with acute pulmonary disease: predictive value of disease distribution as shown on CT

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

Bronchoalveolar lavage. Let's focus on clinical utility

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

Diagnostic value of hemosiderin-containing macrophages in bronchoalveolar lavage

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

Use of bronchoalveolar lavage in immunocompromised children with pneumonia.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

Aspergillus antigen latex test for diagnosis of invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

Immunoblot analyses of the serologic response to Aspergillus fumigatus antigens in experimental invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

Chronic necrotizing pulmonary aspergillosis: a discrete clinical entity.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

Chronic necrotising pneumonia caused by Aspergillus niger

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

Fluconazole failure in the treatment of invasive mycoses

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

Operation for cavitating invasive pulmonary aspergillosis in immunocompromised patients

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

Oral azole drugs as systemic antifungal therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

Combination therapy in experimental invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

Treatment of invasive aspergillosis with itraconazole

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

Low-dose amphotericin B prophylaxis against invasive Aspergillus infections in allogeneic marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

The role of fluconazole in the early treatment and prophylaxis of experimental invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

Problems in management of opportunistic fungal diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

Aspergillosis. The spectrum of the disease in 98 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

The renal transplant patient with fever and pulmonary infiltrates: etiology, clinical manifestations, and management

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

Immunosuppressive effects and infections associated with corticosteroid therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

In vivo interferon-gamma therapy augments the in vitro ability of chronic granulomatous disease neutrophils to damage Aspergillus hyphae

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

Infectious keratitis and cyanoacrylate adhesive.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

Problems in the Diagnosis of Invasive Fungal Diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

The use of amphotericin B in nosocomial fungal infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980002-6

7 January 2021

10.1016/S0049-0172(95)80002-6

Identifiers

DOI

1 reference

20 September 2017

1 reference

PubMed ID

7604298